Edesa Biotech Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +175.8% | +1,093.1% | +64.2% | -67.5% | +451.4% | +70.0% | -28.2% | +24.6% | -40.3% | +52.6% | -51.5% | +88.2% | +35.5% | -20.6% | -23.2% | -57.1% | +254.8% | |
| – | +352.4% | +970.1% | +62.7% | -75.2% | +676.1% | +73.0% | -29.9% | +22.6% | -44.1% | +57.7% | -47.0% | +43.6% | +49.2% | -24.8% | -29.2% | -74.0% | +587.1% | |
| – | +403.3% | +738.3% | +106.9% | -75.9% | +686.8% | +70.8% | -70.5% | +87.5% | -38.4% | -7.6% | +19.1% | +43.4% | +8.7% | -9.5% | -24.4% | -80.7% | +940.4% | |
| – | +403.3% | +738.3% | +106.9% | -75.9% | +686.8% | +76.7% | -35.4% | +27.1% | -42.4% | +56.9% | -51.2% | +43.4% | +8.7% | -9.5% | -24.4% | -80.7% | +940.4% | |
| – | – | – | -93.1% | -56.6% | +950.1% | -68.2% | +178.6% | -45.5% | -98.5% | +3,104.8% | +426.4% | -59.7% | +3,677.0% | -62.0% | -50.1% | -56.8% | +137.3% | |
| – | – | – | – | – | – | – | – | -55.2% | -72.7% | +229.3% | -196.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +50.2% | -99.7% | +225.1% | +889.1% | +139.3% | -36.2% | -72.1% | – | – | – | |
| – | – | – | -13.1% | -16.4% | -19.7% | – | – | – | – | – | – | – | -4.1% | -4.2% | -4.4% | -4.6% | -4.9% | |
| – | -2,688.6% | – | -62.2% | +335.0% | +1,583.6% | -41.9% | -64.9% | -73.8% | -48.5% | +53.7% | -6.4% | +258.3% | -7.7% | +43.1% | -15.7% | -0.5% | -41.2% | |
| – | – | – | -62.2% | +253.2% | +595.4% | -63.7% | +67.6% | -73.8% | -48.5% | +53.7% | -6.4% | +231.4% | -4.7% | +46.8% | -14.9% | +0.6% | -41.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +13.0% | -75.9% | +293.7% | -73.4% | – | |
| – | – | – | – | – | – | -68.2% | +178.6% | +295.7% | -48.5% | +53.7% | -13.9% | +243.9% | -5.5% | +53.8% | -17.7% | +3.8% | -40.5% | |
| – | +208.7% | +919.7% | +85.7% | -81.5% | -468.9% | – | +4.0% | +53.8% | -39.9% | +52.5% | -53.4% | +73.3% | +43.4% | -28.1% | -24.9% | -71.9% | +528.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.3% | +285.5% | +144.1% | +14.9% | +17.9% | +46.9% | +4.9% | +10.9% | -88.7% | +1,843.9% | +41.6% | +87.6% | +40.3% | +21.5% | +36.4% | +11.8% | +77.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.